Fingolimod Lauryl Sulfate
Fingolimod Lauryl Sulfate is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including TASCENSO ODT. Available dosage form: tablet, orally disintegrating.
Drug Details
- Generic Name
- Fingolimod Lauryl Sulfate
- Brand Names
- TASCENSO ODT
- Application Number
- NDA214962
- Sponsor
- Cycle Pharmaceuticals Ltd
- NDC Codes
- 8
- Dosage Forms
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Active Ingredients
- FINGOLIMOD LAURYL SULFATE
Indications and Usage
1 INDICATIONS AND USAGE TASCENSO ODT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. TASCENSO ODT is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )